Microbot Medical (Nasdaq:MBOT) announced today that it filed an FDA investigational device exemption (IDE) application for its surgical robot. Braintree, Massachusetts-based Microbot designed the Liberty surgical robot for potential use in neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities to reduce radiation exposure and physical strain on […]
Microbot Medical
Microbot Medical settles investors’ lawsuit for more than $2M
Microbot Medical (Nasdaq: MBOT), the developer of the Liberty endovascular robotic surgical system, announced today that it has settled a years-old lawsuit involving a securities purchase agreement. Empery Asset Master, Empery Tax Efficient, Empery Tax Efficient II, and Hudson Bay Master Fund sued Microbot Medical in 2020 in the New York state court in New […]
Microbot Medical expands U.S. operations to prep for first in-human clinical study
Microbot Medical, the developer of the Liberty endovascular robotic surgical system, is building on the momentum from the positive results of its good laboratory practices (GLP) pre-clinical study. The company is adding a clinical research associate to support its pending investigational device exemption, or IDE, submission to commence its first-in-human clinical trial. The clinical research […]
Microbot Medical meets objectives in preclinical surgical robot study, seeks FDA IDE
Microbot Medical (Nasdaq:MBOT) today announced the successful completion of its GLP pivotal preclinical surgical robot study. Braintree, Massachusetts-based Microbot completed the study using a porcine model. It operated under the guidelines of FDA-required levels of planning, controlling, monitoring and reporting. Microbot said earlier this month that the study used its Liberty endovascular surgical robotic system […]
Microbot Medical, Corewell collab on telerobotics for endovascular surgical robot
Microbot Medical (Nasdaq:MBOT) announced today that it entered into a collaboration with Corewell Health to enable telerobotic capabilities. The collaboration, separated into multiple phases, seeks to enable telerobotics between remote centers. It aims to do so utilizing the Liberty endovascular robotic surgical system. The Braintree, Massachusetts-based company has plans to submit Liberty for FDA IDE approval […]
Microbot Medical is a step closer to an FDA IDE submission
Microbot Medical today announced the successful completion of its pivotal pre-clinical study of its Liberty endovascular robotic surgical system. The study, performed under good laboratory practice (GLP) and essential for the company’s investigational device exemption (IDE) submission, took place under rigorous FDA guidelines. The study involved pigs. In this study, three interventional radiologists performed 96 […]
Microbot Medical inks deal to expand surgical robot manufacturing capabilities
Microbot Medical (Nasdaq:MBOT) announcd today that it signed a manufacturing agreement with B.Y. Medimor for its surgical robot. Braintree, Massachusetts–based Microbot develops the Liberty single-use endovascular robotic surgical system. It designed Liberty for use in neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities to reduce radiation exposure […]
Microbot Medical completes pre-clinical study of endovascular surgical robot
Microbot Medical (Nasdaq:MBOT) announced today that it successfully completed an extended pre-clinical study of its surgical robot system. Hingham, Massachusetts-based Microbot develops the Liberty single-use endovascular robotic surgical system. It designed Liberty for use in neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities to reduce radiation exposure […]
Microbot Medical raises $9m, set to unveil disposable robotic system
Microbot Medical announced that it raised nearly $9 million in a common stock offering, days after announcing that it is set to unveil its disposable robotic system for multiple procedures later this month. The Hingham, Mass.–based company agreed to sell 900,901 shares of common stock at a purchase price of $11.10 per share. The gross […]
StemCells soars 600% on reverse merger with Israel’s Microbot Medical
Shares in StemCells (NSDQ:STEM) initially soared some 600% this week after the company initiated a reverse merger with Microbot Medical, after the failure of a Phase II trial of StemCells’ spinal cord injury treatment. The merger also saw the resignation of CEO Ian Massey, CFO Gregory Schiffman and a trio of board members, as the team led by […]